Evidence map›Paper›PMID 36416948›Full record

ArticleClinical oral investigations2023

Effect of antioxidant lycopene on human osteoblasts.

U Bengi V, I Saygun, V Bal, E Ozcan, C Kose Ozkan, D Torun, F Avcu, A Kantarcı

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

U Bengi VGulhane Faculty of Dental Medicine, University of Health Sciences, Ankara, Turkey. umutbengi@hotmail.com.ORCID http://orcid.org/0000-0002-2975-8961
I SaygunGulhane Faculty of Dental Medicine, University of Health Sciences, Ankara, Turkey.
V BalMinistry of Health of Turkey, 75Th Year Oral Dental Health Hospital, Ankara, Turkey.
E OzcanGulhane Faculty of Dental Medicine, University of Health Sciences, Ankara, Turkey.
C Kose OzkanGulhane Faculty of Pharmacy, University of Health Sciences, Ankara, Turkey.
D TorunGulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
F AvcuMemorial Ankara Hospital, Ankara, Turkey.
A KantarcıThe Forsyth Institute, Cambridge, MA, USA.
Sağlık Bilimleri Üniversitesi · TRMemorial Ankara Hospital · TRMinistry of Health · TR

Funding

Gulhane Military Medical Academy AR2013/31
6 · The paper itself

Abstract

objectiveThe aim of this in vitro study is to evaluate the effect of antioxidant lycopene on human osteoblasts. MATERIAL AND

methodThe human osteoblast cell line (CRL-11372) was obtained from the American Type Culture Collection (ATCC Manassas, Va) and grown in Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), penicillin (100 U/ml), and streptomycin (100 mg/ ml) at 37 °C in a humidified atmosphere of 5% CO

resultsMTT assay showed that the doses between 10

conclusionResults suggested that lycopene had proliferative effects on human osteoblasts, which may help to increase bone regeneration, and thus, it can be useful in tissue engineering procedures. CLINICAL RELEVANCE: By the help of antioxidants like lycopene capacity, velocity and quality of new bone forming may be increased in periodontal and dental implant treatments.

Indexed as

AntioxidantsOsteoblastsCell DifferentiationCell LineCell ProliferationCells, CulturedHumansLycopeneOsteocalcinAntioxidantsLycopeneOsteocalcinAntioxidantsIn vitro modelOsteoblastPeriodontal healingRegenerationTissue engineering

Identifiers

PMID36416948
OpenAlexW4309746463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.